On the basis of the seroantibodies involved, IMNM can be divided into the following three subtypes: anti-3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) myopathy, anti-signal recognition particle (SRP) myopathy, and seronegative myopathy. This evidence concerns the gene UCN2 and myopathy.